Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Hematology. American Society of Hematology. Education Program
|
December 4, 2020
Transformed lymphoma: what should I do now?
Sonali Smith
Current Treatment Options in Oncology
|
June 22, 2005
Therapeutic options for patients with Hodgkin's disease and non-Hodgkin's lymphoma who relapse after autologous transplant
Koen van Besien, Sonali Smith, Hillard M Lazarus
Journal of Neurosurgery. Spine
|
October 23, 2008
Extranodal hairy cell leukemia presenting in the lumbar spine
David S Rosen, Sonali Smith, Sandeep Gurbuxani, et al.
Oncoimmunology
|
July 9, 2015
Highly clonal regulatory T-cell population in follicular lymphoma - inverse correlation with the diversity of CD8<sup>+</sup> T cells
Xiao Liu, Girish Venkataraman, Jiaying Lin, et al.
Targeted Oncology
|
September 13, 2012
Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastoma
Andres Morales La Madrid, Andres Morales La Madrid, Nicholas Campbell, et al.
Leukemia & Lymphoma
|
September 6, 2007
Successful allogeneic transplantation of patients with suspected prior invasive mold infection
Brian T Hill, Lavayna Kondapalli, Andrew Artz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 22, 2006
Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation
Andrew S Artz, Daniel A Pollyea, Masha Kocherginsky, et al.
Blood
|
February 7, 2019
Serum levels of TARC, MDC, IL-10, and soluble CD163 in Hodgkin lymphoma: a SWOG S0816 correlative study
Eric D Hsi, Hongli Li, Andrew B Nixon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 4, 2011
Bortezomib, bendamustine, and rituximab in patients with relapsed or refractory follicular lymphoma: the phase II VERTICAL study
Nathan Fowler, Brad S Kahl, Peter Lee, et al.
Hemasphere
|
July 11, 2022
A Retrospective Cohort Study of Treatment Outcomes of Adult Patients With Relapsed or Refractory Follicular Lymphoma (ReCORD-FL)
Gilles Salles, Stephen J Schuster, Luca Fischer, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Hematology. American Society of Hematology. Education Program
|
December 4, 2020
Transformed lymphoma: what should I do now?
Sonali Smith
Current Treatment Options in Oncology
|
June 22, 2005
Therapeutic options for patients with Hodgkin's disease and non-Hodgkin's lymphoma who relapse after autologous transplant
Koen van Besien, Sonali Smith, Hillard M Lazarus
Journal of Neurosurgery. Spine
|
October 23, 2008
Extranodal hairy cell leukemia presenting in the lumbar spine
David S Rosen, Sonali Smith, Sandeep Gurbuxani, et al.
Oncoimmunology
|
July 9, 2015
Highly clonal regulatory T-cell population in follicular lymphoma - inverse correlation with the diversity of CD8<sup>+</sup> T cells
Xiao Liu, Girish Venkataraman, Jiaying Lin, et al.
Targeted Oncology
|
September 13, 2012
Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastoma
Andres Morales La Madrid, Andres Morales La Madrid, Nicholas Campbell, et al.
Leukemia & Lymphoma
|
September 6, 2007
Successful allogeneic transplantation of patients with suspected prior invasive mold infection
Brian T Hill, Lavayna Kondapalli, Andrew Artz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 22, 2006
Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation
Andrew S Artz, Daniel A Pollyea, Masha Kocherginsky, et al.
Blood
|
February 7, 2019
Serum levels of TARC, MDC, IL-10, and soluble CD163 in Hodgkin lymphoma: a SWOG S0816 correlative study
Eric D Hsi, Hongli Li, Andrew B Nixon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 4, 2011
Bortezomib, bendamustine, and rituximab in patients with relapsed or refractory follicular lymphoma: the phase II VERTICAL study
Nathan Fowler, Brad S Kahl, Peter Lee, et al.
Hemasphere
|
July 11, 2022
A Retrospective Cohort Study of Treatment Outcomes of Adult Patients With Relapsed or Refractory Follicular Lymphoma (ReCORD-FL)
Gilles Salles, Stephen J Schuster, Luca Fischer, et al.
Page
of 3